The fellowships provide five years of funding to doctoral students in applied science, engineering, and mathematics who have “the extraordinary creativity and principled leadership necessary to tackle problems others can’t solve.”
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
The Fulbright US Student Program funds research, study, and teaching opportunities abroad.
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.
The Institute also ranks second in five subject areas.
Professors Adam Martin and Joel Volman explain the genesis, scope, and objectives of the recently launched Task Force on the MIT Undergraduate Academic Program.
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
Software allows scientists to model shapeshifting proteins in native cellular environments.
Materials from MIT’s Distinctive Collections reveal stories of women at the Institute.
Nine postdocs and research scientists honored for contributions to the Institute.
A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.
Albert Almada PhD ’13 studies the mechanics of how stem cells rebuild tissues. “Digging deep into the science is what MIT taught me,” he says.
Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.